Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection

Journal of Virology

Volumn 85, Issue 6, 2011, Pages 2793-2802

  Tong, Yimin ^a   Zhu, Yongzhe ^a   Xia, Xueshan ^b   Liu, Yuan ^a   Feng, Yue ^b   Hua, Xian ^a   Chen, Zhihui ^c   Ding, Hui ^a   Gao, Li ^b   Wang, Yongzhi ^a   Feitelson, Mark A ^d   Zhao, Ping ^a   Qi, Zhong Tian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; CLAUDIN 1; OCCLUDIN; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN E2;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCANDENTIA; SUPERNATANT; VIRION; VIRUS INFECTIVITY;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD36; CELL LINE; DISEASE MODELS, ANIMAL; HEPACIVIRUS; HUMANS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; SEQUENCE ANALYSIS, DNA; TUPAIA; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

ANIMALIA; HEPATITIS C VIRUS; TUPAIA; TUPAIA BELANGERI; TUPAIIDAE;

EID: 79952430951     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01818-10     Document Type: Article

References (45)

1. Amako, Y., et al. 2010. Pathogenesis of hepatitis C virus infection in Tupaia belangeri. J. Virol. 84:303-311.
2. Barth, H., et al. 2005. Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes. J. Virol. 79:5774-5785. (Pubitemid 40548246)
3. Bartosch, B., J. Dubuisson, and F. L. Cosset. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197:633-642.
4. Blight, K. J., J. A. McKeating, and C. M. Rice. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76:13001-13014.
5. Burlone, M. E., and A. Budkowska. 2009. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J. Gen. Virol. 90:1055-1070.
6. Cao, J., E. B. Yang, J. J. Su, Y. Li, and P. Chow. 2003. The tree shrews: adjuncts and alternatives to primates as models for biomedical research. J. Med. Primatol. 32:123-130.
7. Catanese, M. T., et al. 2010. Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants. J. Virol. 84:34-43.
8. Cukierman, L., L. Meertens, C. Bertaux, F. Kajumo, and T. Dragic. 2009. Residues in a highly conserved claudin-1 motif are required for hepatitis C virus entry and mediate the formation of cell-cell contacts. J. Virol. 83:5477-5484.
9. Darai, G., A. Rosen, J. Scholz, and H. Gelderblom. 1983. Induction of generalized and lethal herpesvirus infection in the tree shrew by intrahepatic transfection of herpes simplex virus DNA. J. Virol. Methods 7:305-314. (Pubitemid 14216780)
10. Drummer, H. E., K. A. Wilson, and P. Poumbourios. 2002. Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81. J. Virol. 76:11143-11147. (Pubitemid 35176232)
11. Dubuisson, J. 2000. Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. Curr. Top. Microbiol. Immunol. 242:135-148.
12. Evans, M. J., et al. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-805. (Pubitemid 46582027)
13. Flint, M., et al. 2000. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J. Virol. 74:702-709. (Pubitemid 30036206)
14. Flint, M., et al. 1999. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73:6235-6244. (Pubitemid 29327798)
15. Fournier, C., et al. 1998. In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J. Gen. Virol. 79(10):2367-2374.
16. Galun, E., et al. 1995. Hepatitis C virus viremia in SCID→BNX mouse chimera. J. Infect. Dis. 172:25-30.
17. Grove, J., et al. 2007. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J. Virol. 81:3162-3169. (Pubitemid 46456625)
18. Guitart, A., et al. 2005. Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-kappaB nuclear translocation. J. Gen. Virol. 86: 3065-3074.
19. Helle, F., and J. Dubuisson. 2008. Hepatitis C virus entry into host cells. Cell. Mol. Life Sci. 65:100-112.
20. Hsu, M., et al. 2003. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. U. S. A. 100:7271-7276.
21. Jia, Z. S., et al. 2008. Scavenger receptor class B type I mediates cell entry of hepatitis C virus. J. Int. Med. Res. 36:1319-1325.
22. Keam, S. J., and R. S. Cvetkovic. 2008. Peginterferon-alpha-2a (40 kD) plus ribavirin: a review of its use in the management of chronic hepatitis C mono-infection. Drugs 68:1273-1317.
23. Köck, J., et al. 2001. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J. Virol. 75:5084-5089. (Pubitemid 32448530)
24. Lindenbach, B. D., et al. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626. (Pubitemid 41033648)
25. Mercer, D. F., et al. 2001. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 7:927-933.
26. Molina, S., et al. 2008. Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J. Virol. 82:569-574. (Pubitemid 350309172)
27. Op De Beeck, A., L. Cocquerel, and J. Dubuisson. 2001. Biogenesis of hepatitis C virus envelope glycoproteins. J. Gen. Virol. 82:2589-2595.
28. Pawlotsky, J. M. 2006. Therapy of hepatitis C: from empiricism to eradication. Hepatology 43:S207-S220.
29. Pileri, P., et al. 1998. Binding of hepatitis C virus to CD81. Science 282:938-941. (Pubitemid 28507525)
30. Ploss, A., et al. 2009. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882-886.
31. Scarselli, E., et al. 2002. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21:5017-5025.
32. Seeff, L. B. 2002. Natural history of chronic hepatitis C. Hepatology 36:S35-S46. (Pubitemid 35253462)
33. Shepard, C. W., L. Finelli, and M. J. Alter. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5:558-567.
34. Sumpter, R., Jr., et al. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-2699.
35. Tian, Z. F., et al. 2009. Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81. World J. Gastroenterol. 15:240-244.
36. von Hahn, T., and C. M. Rice. 2008. Hepatitis C virus entry. J. Biol. Chem. 283:3689-3693.
37. Wakita, T., et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
38. Walter, E., R. Keist, B. Niederost, I. Pult, and H. E. Blum. 1996. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24:1-5.
39. Wu, G. Y., et al. 2005. A novel immunocompetent rat model of HCV infection and hepatitis. Gastroenterology 128:1416-1423. (Pubitemid 40712190)
40. Xie, Z. C., et al. 1998. Transmission of hepatitis C virus infection to tree shrews. Virology 244:513-520.
41. Yoneyama, M., et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.
42. Zeisel, M. B., et al. 2007. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 46:1722-1731.
43. Zhang, J., et al. 2004. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 78:1448-1455. (Pubitemid 38095855)
44. Zhao, X., et al. 2002. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. J. Clin. Invest. 109:221-232.
45. Zhong, J., et al. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U. S. A. 102:9294-9299.